---
title: "Biotech reverse merger and M&A tracker"
url: "https://aibio.space/reverse-merger-tracker/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "Reverse mergers, takeovers, tender offers, asset sales and control changes at public biotech companies, newest first, with the ownership split where the…"
---

Tracker

# Reverse merger and M&A tracker

Reverse mergers, takeovers, tender offers, asset sales and control changes at public biotech companies, newest first, with the ownership split where the filing gives it.

Updated October 31, 2026. 260 entries. [Download as CSV](https://aibio.space/reverse-merger-tracker.csv). Free to cite with a link to this page. [All trackers](https://aibio.space/trackers/).

- **162**Other deal
- **38**Takeover
- **32**Asset sale or purchase
- **20**Deal ended
- **8**Reverse merger

| Date | Company | Type | What happened |
|---|---|---|---|
| 2026-10-27 | InMed Pharmaceuticals [INM](https://aibio.space/companies/inmed-pharmaceuticals/) | Other deal | [InMed sets November 5 record date for CVRs tied to Mentari merger](https://aibio.space/news/inmed-sets-november-5-record-date-cvrs-tied-mentari-merger/) |
| 2026-10-26 | Rallybio [RLYB](https://aibio.space/companies/rallybio/) | Other deal | [Rallybio declares estimated $82.7 million cash distribution tied to Avenzo merger](https://aibio.space/news/rallybio-declares-estimated-82-7-million-cash-distribution-tied-avenzo/) |
| 2026-10-26 | Skye Bioscience [SKYE](https://aibio.space/companies/skye-bioscience/) | Other deal | [Skye Bioscience files preliminary proxy for its Redx Pharma acquisition](https://aibio.space/news/skye-bioscience-files-preliminary-proxy-redx-pharma-acquisition/) |
| 2026-10-23 | Bolt Biotherapeutics [BOLT](https://aibio.space/companies/bolt-biotherapeutics/) | Reverse merger | [Bolt Biotherapeutics buys Prana Therapies and raises $120 million](https://aibio.space/news/bolt-biotherapeutics-buys-prana-therapies-raises-120-million/) |
| 2026-10-21 |  | Reverse merger | [Biotech reverse mergers reach highest count since 2021 as PIPEs return, J.P. Morgan says](https://aibio.space/news/biotech-reverse-mergers-reach-highest-count-since-2021-pipes-return/) |
| 2026-10-19 | Silence Therapeutics [SLN](https://aibio.space/companies/silence-therapeutics/) | Takeover | [Merck KGaA agrees to buy Silence Therapeutics for $20 per ADS to get PV drug divesiran](https://aibio.space/news/merck-kgaa-agrees-buy-silence-therapeutics-20-ads-get-pv-drug/) |
| 2026-10-16 | MiMedx Group [MDXG](https://aibio.space/companies/mimedx/) | Deal ended | [MiMedx and Sanara MedTech receive FTC Second Request on merger](https://aibio.space/news/mimedx-sanara-medtech-receive-ftc-second-request-merger/) |
| 2026-10-16 | MiMedx Group [MDXG](https://aibio.space/companies/mimedx/) | Deal ended | [MiMedx and Sanara receive FTC Second Request on proposed merger](https://aibio.space/news/mimedx-sanara-receive-ftc-second-request-proposed-merger/) |
| 2026-10-15 | Rallybio [RLYB](https://aibio.space/companies/rallybio/) | Reverse merger | [Rallybio holders to own 2.8% of the combined company in Avenzo reverse merger](https://aibio.space/news/rallybio-holders-own-2-8-percent-combined-company-avenzo-reverse/) |
| 2026-10-15 | Aditxt [ADTX](https://aibio.space/companies/aditxt/) | Deal ended | [Aditxt unit Ignite Proteomics and Copley Acquisition Corp end SPAC merger deal](https://aibio.space/news/aditxt-unit-ignite-proteomics-copley-acquisition-corp-end-spac-merger/) |
| 2026-10-14 | AIBOTICS, INC. [AIBT](https://aibio.space/companies/aibotics/) | Other deal | [Aibotics completes purchase of PlayJamaica robotics and drone assets](https://aibio.space/news/aibotics-completes-purchase-playjamaica-robotics-drone-assets/) |
| 2026-10-14 | Eton Pharmaceuticals [ETON](https://aibio.space/companies/eton-pharmaceuticals/) | Other deal | [Eton Pharmaceuticals pays $10.0 million upfront for US rights to Aquestive's Libervant](https://aibio.space/news/eton-pharmaceuticals-pays-10-0-million-upfront-us-rights-aquestives/) |
| 2026-10-13 | LogicMark [LGMK](https://aibio.space/companies/logicmark/) | Other deal | [LogicMark completes merger, holders receive $1.31 a share in cash](https://aibio.space/news/logicmark-completes-merger-holders-receive-1-31-share-cash/) |
| 2026-10-13 | Pulmatrix [PULM](https://aibio.space/companies/pulmatrix/) | Other deal | [Pulmatrix stockholders to vote October 26, 2026 on Eos SENOLYTIX merger](https://aibio.space/news/pulmatrix-stockholders-vote-october-26-2026-eos-senolytix-merger/) |
| 2026-10-13 | Senti Biosciences Holdings [SNTI](https://aibio.space/companies/senti-biosciences/) | Other deal | [Senti Biosciences adjourns annual meeting to seek more votes for merger proposal](https://aibio.space/news/senti-biosciences-adjourns-annual-meeting-seek-more-votes-merger/) |
| 2026-10-13 | Alaunos Therapeutics [TCRT](https://aibio.space/companies/alaunos-therapeutics/) | Other deal | [Alaunos Therapeutics acquires Velaris, closes $350 million private placement](https://aibio.space/news/alaunos-therapeutics-acquires-velaris-closes-350-million-private/) |
| 2026-10-09 | Passage Bio [PASG](https://aibio.space/companies/passage-bio/) | Reverse merger | [Passage Bio holders would keep about 6% in Remix reverse merger, vote Nov 5](https://aibio.space/news/passage-bio-holders-would-keep-about-6-percent-remix-reverse-merger/) |
| 2026-10-08 | Boundless Bio [BOLD](https://aibio.space/companies/boundless-bio/) | Other deal | [Boundless Bio files S-4 for Serapha merger; partner later reports early SERP-01 data](https://aibio.space/news/boundless-bio-files-s-4-serapha-merger-partner-later-reports-early/) |
| 2026-10-08 | Pacira BioSciences, Viatris [PCRX](https://aibio.space/companies/pacira-biosciences/)[VTRS](https://aibio.space/companies/viatris/) | Takeover | [Viatris agrees to acquire Pacira BioSciences for $36.50 per share in cash](https://aibio.space/news/viatris-agrees-acquire-pacira-biosciences-36-50-share-cash/) |
| 2026-10-07 | Jasper Therapeutics [JSPR](https://aibio.space/companies/jasper-therapeutics/) | Other deal | [Jasper Therapeutics offers $0.324 per warrant to buy back up to 12,345,707 warrants](https://aibio.space/news/jasper-therapeutics-offers-0-324-warrant-buy-back-up-12-345-707/) |
| 2026-10-06 | Hepion Pharmaceuticals [HEPA](https://aibio.space/companies/hepion-pharmaceuticals/) | Other deal | [Hepion acquires Gravitas Life Sciences in a related party deal](https://aibio.space/news/hepion-acquires-gravitas-life-sciences-related-party-deal/) |
| 2026-10-06 | Adia Med [ADIA](https://aibio.space/companies/adia-med/) | Other deal | [Adia Med agrees to sell 30% of Adia Labs to QCM Biologics for $1,500,000](https://aibio.space/news/adia-med-agrees-sell-30-percent-adia-labs-qcm-biologics-1-500-000/) |
| 2026-10-06 | BeyondSpring [BYSI](https://aibio.space/companies/beyondspring/) | Asset sale or purchase | [BeyondSpring completes sale of subsidiary holding China unit Bulin for non-cash consideration](https://aibio.space/news/beyondspring-completes-sale-subsidiary-holding-china-unit-bulin-non/) |
| 2026-10-06 | BeyondSpring [BYSI](https://aibio.space/companies/beyondspring/) | Asset sale or purchase | [BeyondSpring sells BeyondSpring Ltd. for trial data rights instead of cash](https://aibio.space/news/beyondspring-sells-beyondspring-ltd-trial-data-rights-instead-cash/) |
| 2026-10-01 | ENDRA Life Sciences [NDRA](https://aibio.space/companies/endra-life-sciences/) | Deal ended | [ENDRA amends merger agreement with ASP Isotopes and Renergen](https://aibio.space/news/endra-amends-merger-agreement-asp-isotopes-renergen/) |
| 2026-10-01 | SpyGlass Pharma, Santen Pharmaceutical Co. [SGP](https://aibio.space/companies/spyglass-pharma/)[4536](https://aibio.space/companies/santen-pharmaceutical/)[BLCO](https://aibio.space/companies/bausch-lomb/) | Asset sale or purchase | [SpyGlass buys lens maker Advanced Vision Science from Santen for about $13 million](https://aibio.space/news/spyglass-buys-lens-maker-advanced-vision-science-santen-about-13/) |
| 2026-10-01 | Mangoceuticals [MGRX](https://aibio.space/companies/mangoceuticals/) | Other deal | [Mangoceuticals unit MangoRx IP gets $2.5 million commitment, receives $1.75 million](https://aibio.space/news/mangoceuticals-unit-mangorx-ip-gets-2-5-million-commitment-receives-1/) |
| 2026-09-30 | Chemomab Therapeutics [CMMB](https://aibio.space/companies/chemomab-therapeutics/) | Deal ended | [Chemomab amends domestication merger terms ahead of Scipher Medicine deal](https://aibio.space/news/chemomab-amends-domestication-merger-terms-ahead-scipher-medicine-deal/) |
| 2026-09-29 | Lexeo Therapeutics [LXEO](https://aibio.space/companies/lexeo-therapeutics/) | Other deal | [Lexeo completes Mantle Therapeutics deal for $5,300,000 cash plus $3,000,000 in stock](https://aibio.space/news/lexeo-completes-mantle-therapeutics-deal-5-300-000-cash-plus-3-000-000/) |
| 2026-09-28 | Lifecore Biomedical [LFCR](https://aibio.space/companies/lifecore-biomedical/) | Other deal | [Lifecore Biomedical agrees to $6.28 a share cash sale to Webster Equity Partners](https://aibio.space/news/lifecore-biomedical-agrees-6-28-share-cash-sale-webster-equity/) |
| 2026-09-23 | Glucotrack [GCTK](https://aibio.space/companies/glucotrack/) | Other deal | [Glucotrack CEO outlines Lokahi priorities for LT-100 and the ai² platform](https://aibio.space/news/glucotrack-ceo-outlines-lokahi-priorities-lt-100-ai2-platform/) |
| 2026-09-23 | Zymeworks [ZYME](https://aibio.space/companies/zymeworks/) | Other deal | [Zymeworks completes Theravance Biopharma acquisition, with $350 million in senior secured notes](https://aibio.space/news/zymeworks-completes-theravance-biopharma-acquisition-350-million/) |
| 2026-09-17 | Impact BioMedical, ProPhase Labs [IBO](https://aibio.space/companies/impact-biomedical/)[PRPH](https://aibio.space/companies/prophase-labs/) | Other deal | [Impact BioMedical reports Zoar F-4 filing in business combination](https://aibio.space/news/impact-biomedical-reports-zoar-f-4-filing-business-combination/) |
| 2026-09-17 | AETHLON MEDICAL INC [AEMD](https://aibio.space/companies/aethlon-medical/) | Other deal | [Aethlon to merge with North Immunology in an all-stock deal](https://aibio.space/news/aethlon-merge-north-immunology-all-stock-deal/) |
| 2026-09-10 | Tarsus Pharmaceuticals [TARS](https://aibio.space/companies/tarsus-pharmaceuticals/) | Other deal | [Tarsus Pharmaceuticals completes Alkeus acquisition with $270,000,000 in cash up front](https://aibio.space/news/tarsus-pharmaceuticals-completes-alkeus-acquisition-270-000-000-cash/) |
| 2026-09-04 | iSpecimen [ISPC](https://aibio.space/companies/ispecimen/) | Takeover | [iSpecimen agrees to buy Foldlab AI software assets for $4,500,000](https://aibio.space/news/ispecimen-agrees-buy-foldlab-ai-software-assets-4-500-000/) |
| 2026-09-04 | Clearmind Medicine [CMND](https://aibio.space/companies/clearmind-medicine/) | Takeover | [Clearmind Medicine agrees to buy 51% of Charging Robotics for $2.5 million](https://aibio.space/news/clearmind-medicine-agrees-buy-51-percent-charging-robotics-2-5-million/) |
| 2026-09-01 | International Stem Cell CORP [ISCO](https://aibio.space/companies/international-stem-cell/) | Asset sale or purchase | [International Stem Cell completes sale of Lifeline Cell Technology to ATCC](https://aibio.space/news/international-stem-cell-completes-sale-lifeline-cell-technology-atcc/) |
| 2026-08-27 | Korsana Biosciences [KRSA](https://aibio.space/companies/korsana-biosciences/) | Other deal | [Cyclerion (now Korsana Biosciences) shareholders approve merger issuance and 1-for-7 reverse split](https://aibio.space/news/cyclerion-now-korsana-biosciences-shareholders-approve-merger-issuance/) |
| 2026-08-25 | PTC Therapeutics [PTCT](https://aibio.space/companies/ptc-therapeutics/) | Takeover | [PTC agrees to buy Sangamo's Fabry gene therapy ST-920 in bankruptcy](https://aibio.space/news/ptc-agrees-buy-sangamos-fabry-gene-therapy-st-920-bankruptcy/) |
| 2026-08-24 | Arbutus Biopharma [ABUS](https://aibio.space/companies/arbutus-biopharma/) | Takeover | [Arbutus Biopharma starts tender offer for up to US$230 million of its shares](https://aibio.space/news/arbutus-biopharma-starts-tender-offer-up-us-230-million-shares/) |
| 2026-08-21 | Elutia [ELUT](https://aibio.space/companies/elutia/) | Other deal | [Elutia completes SimpliDerm business sale to Cellution Biologics, receives $7.7 million](https://aibio.space/news/elutia-completes-simpliderm-business-sale-cellution-biologics-receives/) |
| 2026-08-21 | Arbutus Biopharma [ABUS](https://aibio.space/companies/arbutus-biopharma/) | Takeover | [Arbutus plans US$230 million Dutch auction tender offer for its shares](https://aibio.space/news/arbutus-plans-us-230-million-dutch-auction-tender-offer-shares/) |
| 2026-08-18 | Baxter International [BAX](https://aibio.space/companies/baxter-international/) | Takeover | [Baxter raises note tender offer cap to $600 million after early results](https://aibio.space/news/baxter-raises-note-tender-offer-cap-600-million-after-early-results/) |
| 2026-08-17 | ENDRA Life Sciences, ASP Isotopes [NDRA](https://aibio.space/companies/endra-life-sciences/)[ASPI](https://aibio.space/companies/asp-isotopes/) | Other deal | [ENDRA reports second quarter 2026 results and merger progress](https://aibio.space/news/endra-reports-second-quarter-2026-results-merger-progress/) |
| 2026-08-17 | Fulcrum Therapeutics [FULC](https://aibio.space/companies/fulcrum-therapeutics/) | Other deal | [Fulcrum Therapeutics agrees to all-stock merger with Slate Medicines](https://aibio.space/news/fulcrum-therapeutics-agrees-all-stock-merger-slate-medicines/) |
| 2026-08-12 | Bio Green Med Solution [BGMS](https://aibio.space/companies/bio-green-med-solution/) | Other deal | [Bio Green Med reports second-quarter results and updates Future NRG deal](https://aibio.space/news/bio-green-med-reports-second-quarter-results-updates-future-nrg-deal/) |
| 2026-08-06 | Tarsus Pharmaceuticals [TARS](https://aibio.space/companies/tarsus-pharmaceuticals/) | Takeover | [Tarsus agrees to buy Alkeus for $270,000,000 in cash and $180,000,000 in stock](https://aibio.space/news/tarsus-agrees-buy-alkeus-270-000-000-cash-180-000-000-stock/) |
| 2026-08-06 | Ensysce Biosciences [ENSC](https://aibio.space/companies/ensysce-biosciences/) | Asset sale or purchase | [Ensysce Biosciences buys Cy Biopharma, agrees to two-tranche private placement of Series C stock](https://aibio.space/news/ensysce-biosciences-buys-cy-biopharma-agrees-two-tranche-private/) |
| 2026-08-05 | Eton Pharmaceuticals [ETON](https://aibio.space/companies/eton-pharmaceuticals/) | Other deal | [Eton Pharmaceuticals licenses ASN-001 from Auson for $3.0 million upfront](https://aibio.space/news/eton-pharmaceuticals-licenses-asn-001-auson-3-0-million-upfront/) |
| 2026-08-03 | LogicMark [LGMK](https://aibio.space/companies/logicmark/) | Other deal | [LogicMark agrees to $1.31 per share cash merger with Langham Project](https://aibio.space/news/logicmark-agrees-1-31-share-cash-merger-langham-project/) |
| 2026-08-03 | Lisata Therapeutics [LSTA](https://aibio.space/companies/lisata-therapeutics/) | Takeover | [Lisata cuts 72% of staff after failed Kuva buyout, then merges with Marea](https://aibio.space/news/lisata-cuts-72-percent-staff-after-failed-kuva-buyout-then-merges/) |
| 2026-07-29 | SYNLOGIC, INC. [SYBX](https://aibio.space/companies/synlogic/) | Other deal | [Synlogic to merge with Caldera Therapeutics in all-stock deal](https://aibio.space/news/synlogic-merge-caldera-therapeutics-all-stock-deal/) |
| 2026-07-29 | Processa Pharmaceuticals [PCSA](https://aibio.space/companies/processa-pharmaceuticals/) | Other deal | [Processa acquires Vidya Therapeutics with $200 million placement](https://aibio.space/news/processa-acquires-vidya-therapeutics-200-million-placement/) |
| 2026-07-29 | FOXO TECHNOLOGIES INC. [FOXO](https://aibio.space/companies/foxo-technologies/) | Takeover | [Vector BioSource agrees to buy four blood collection centers](https://aibio.space/news/vector-biosource-agrees-buy-four-blood-collection-centers/) |
| 2026-07-29 | TRAFALGAR INTERNATIONAL, INC. [GCAND](https://aibio.space/companies/trafalgar-international-gcand/) | Other deal | [Trafalgar adds three new officers and three incoming directors](https://aibio.space/news/trafalgar-adds-three-new-officers-three-incoming-directors/) |
| 2026-07-23 | Neuphoria Therapeutics, Scancell Holdings Plc [NEUP](https://aibio.space/companies/neuphoria-therapeutics/)[SCLP](https://aibio.space/companies/scancell/) | Other deal | [Neuphoria and Scancell agree to all-share merger with up to $89 million financing](https://aibio.space/news/neuphoria-scancell-agree-all-share-merger-up-89-million-financing/) |
| 2026-07-15 | Senti Biosciences Holdings [SNTI](https://aibio.space/companies/senti-biosciences/) | Other deal | [Senti Biosciences signs merger agreement with Celadon affiliate, with CVRs tied to SENTI-202](https://aibio.space/news/senti-biosciences-signs-merger-agreement-celadon-affiliate-cvrs-tied/) |
| 2026-07-14 | NextCure [NXTC](https://aibio.space/companies/nextcure/) | Other deal | [NextCure signs merger agreement with Avere Therapeutics alongside $320 million private placement](https://aibio.space/news/nextcure-signs-merger-agreement-avere-therapeutics-alongside-320/) |
| 2026-07-13 | Matinas Biopharma Holdings [MTNB](https://aibio.space/companies/matinas-biopharma/) | Other deal | [Matinas plans GH Power combination and sells MAT2203 to Azurity](https://aibio.space/news/matinas-plans-gh-power-combination-sells-mat2203-azurity/) |
| 2026-07-07 | MacroGenics [MGNX](https://aibio.space/companies/macrogenics/) | Asset sale or purchase | [MacroGenics completes sale of CDMO manufacturing business to Bora for $122.5 million](https://aibio.space/news/macrogenics-completes-sale-cdmo-manufacturing-business-bora-122-5/) |
| 2026-07-07 | MacroGenics [MGNX](https://aibio.space/companies/macrogenics/) | Asset sale or purchase | [MacroGenics completes sale of manufacturing operations to Bora for $122.5 million](https://aibio.space/news/macrogenics-completes-sale-manufacturing-operations-bora-122-5-million/) |
| 2026-07-02 | NOMAD POWER SOLUTIONS, INC. [NMAD](https://aibio.space/companies/nomad-power-solutions/) | Other deal | [LIXTE completes merger with NOMAD Transportable Power Systems](https://aibio.space/news/lixte-completes-merger-nomad-transportable-power-systems/) |
| 2026-07-01 | Cumberland Pharmaceuticals [CPIX](https://aibio.space/companies/cumberland-pharmaceuticals/) | Other deal | [Cumberland Pharmaceuticals closes $100 million asset sale to Apotex affiliates](https://aibio.space/news/cumberland-pharmaceuticals-closes-100-million-asset-sale-apotex/) |
| 2026-07-01 | Cumberland Pharmaceuticals [CPIX](https://aibio.space/companies/cumberland-pharmaceuticals/) | Other deal | [Cumberland Pharmaceuticals closes $100 million branded-product deal with Apotex](https://aibio.space/news/cumberland-pharmaceuticals-closes-100-million-branded-product-deal/) |
| 2026-06-29 | Zymeworks [ZYME](https://aibio.space/companies/zymeworks/) | Takeover | [Zymeworks agrees to buy Theravance Biopharma for $17 per share, about $929 million](https://aibio.space/news/zymeworks-agrees-buy-theravance-biopharma-17-share-about-929-million/) |
| 2026-06-17 | Rigel Pharmaceuticals [RIGL](https://aibio.space/companies/rigel-pharmaceuticals/) | Other deal | [Rigel Pharmaceuticals completes vepdegestrant license, pays $70.0 million upfront](https://aibio.space/news/rigel-pharmaceuticals-completes-vepdegestrant-license-pays-70-0/) |
| 2026-06-17 | Rigel Pharmaceuticals [RIGL](https://aibio.space/companies/rigel-pharmaceuticals/) | Other deal | [Rigel completes vepdegestrant license from Arvinas and Pfizer, pays $70.0 million](https://aibio.space/news/rigel-completes-vepdegestrant-license-arvinas-pfizer-pays-70-0-million/) |
| 2026-06-16 | Prestige Consumer Healthcare [PBH](https://aibio.space/companies/prestige-consumer-healthcare/) | Other deal | [Prestige Consumer Healthcare closes $1.045 billion Breathe Right acquisition, signs new term loan](https://aibio.space/news/prestige-consumer-healthcare-closes-1-045-billion-breathe-right/) |
| 2026-06-12 | Rocket Pharmaceuticals [RCKT](https://aibio.space/companies/rocket-pharmaceuticals/) | Asset sale or purchase | [Rocket Pharmaceuticals closes $180 million sale of priority review voucher](https://aibio.space/news/rocket-pharmaceuticals-closes-180-million-sale-priority-review-voucher/) |
| 2026-06-11 | Adial Pharmaceuticals [ADIL](https://aibio.space/companies/adial-pharmaceuticals/) | Other deal | [Adial acquires Azora Therapeutics and announces up to $64 million financing](https://aibio.space/news/adial-acquires-azora-therapeutics-announces-up-64-million-financing/) |
| 2026-06-11 | Veraxa Biotech [VRXA](https://aibio.space/companies/veraxa-biotech/) | Other deal | [Veraxa Biotech closes Voyager SPAC merger, Nasdaq trading starts June 11](https://aibio.space/news/veraxa-biotech-closes-voyager-spac-merger-nasdaq-trading-starts-june/) |
| 2026-06-09 | Aditxt [ADTX](https://aibio.space/companies/aditxt/) | Other deal | [Aditxt signs deal to take Ignite Proteomics public at $150 million value](https://aibio.space/news/aditxt-signs-deal-take-ignite-proteomics-public-150-million-value/) |
| 2026-06-04 | Bio Green Med Solution [BGMS](https://aibio.space/companies/bio-green-med-solution/) | Takeover | [Bio Green Med agrees to all-stock deal to acquire Future NRG](https://aibio.space/news/bio-green-med-agrees-all-stock-deal-acquire-future-nrg/) |
| 2026-06-03 | CONMED [CNMD](https://aibio.space/companies/conmed/) | Takeover | [CONMED agrees to buy back 2.250% convertible notes due 2027 for cash](https://aibio.space/news/conmed-agrees-buy-back-2-250-percent-convertible-notes-due-2027-cash/) |
| 2026-06-03 | REGENXBIO [RGNX](https://aibio.space/companies/regenxbio/) | Other deal | [REGENXBIO starts stock option exchange offer for non-executive employees](https://aibio.space/news/regenxbio-starts-stock-option-exchange-offer-non-executive-employees/) |
| 2026-06-03 | REGENXBIO [RGNX](https://aibio.space/companies/regenxbio/) | Other deal | [REGENXBIO starts stock option exchange for non-executive employees](https://aibio.space/news/regenxbio-starts-stock-option-exchange-non-executive-employees/) |
| 2026-05-27 | OSR Health [OSRH](https://aibio.space/companies/osr-health/) | Takeover | [OSR Health agrees to buy VXM01 assets from Vaximm for $30,000,000](https://aibio.space/news/osr-health-agrees-buy-vxm01-assets-vaximm-30-000-000/) |
| 2026-05-19 | InMed Pharmaceuticals [INM](https://aibio.space/companies/inmed-pharmaceuticals/) | Other deal | [InMed agrees to all-stock merger with Mentari Therapeutics](https://aibio.space/news/inmed-agrees-all-stock-merger-mentari-therapeutics/) |
| 2026-05-19 | Parabilis Medicines [PBLS](https://aibio.space/companies/parabilis-medicines/) | Takeover | [Parabilis Medicines files for IPO; Regeneron agrees to buy about $75.0 million of stock](https://aibio.space/news/parabilis-medicines-files-ipo-regeneron-agrees-buy-about-75-0-million/) |
| 2026-05-15 | HEALTHY EXTRACTS INC. [HYEX](https://aibio.space/companies/healthy-extracts/) | Other deal | [Healthy Extracts acquires Adli Gummies, which does business as Imaraïs Beauty](https://aibio.space/news/healthy-extracts-acquires-adli-gummies-which-does-business-imarais/) |
| 2026-05-15 | Cumberland Pharmaceuticals [CPIX](https://aibio.space/companies/cumberland-pharmaceuticals/) | Asset sale or purchase | [Cumberland Pharmaceuticals files proxy for $100 million asset sale to Apotex](https://aibio.space/news/cumberland-pharmaceuticals-files-proxy-100-million-asset-sale-apotex/) |
| 2026-05-12 | Collegium Pharmaceutical [COLL](https://aibio.space/companies/collegium-pharmaceutical/) | Other deal | [Collegium completes $650 million AZSTARYS acquisition, funded with cash and $300 million term loan](https://aibio.space/news/collegium-completes-650-million-azstarys-acquisition-funded-cash-300/) |
| 2026-05-12 | Collegium Pharmaceutical [COLL](https://aibio.space/companies/collegium-pharmaceutical/) | Other deal | [Collegium completes AZSTARYS purchase for about $650 million, raises 2026 guidance](https://aibio.space/news/collegium-completes-azstarys-purchase-about-650-million-raises-2026/) |
| 2026-05-11 | Aurinia Pharmaceuticals [AUPH](https://aibio.space/companies/aurinia-pharmaceuticals/) | Takeover | [Aurinia completes Kezar Life Sciences acquisition after tender offer at $6.955 per share plus CVR](https://aibio.space/news/aurinia-completes-kezar-life-sciences-acquisition-after-tender-offer-6/) |
| 2026-05-04 | Lisata Therapeutics [LSTA](https://aibio.space/companies/lisata-therapeutics/) | Takeover | [Lisata and Kuva Labs delay tender offer start to May 29, Kuva to pay up to $1.1 million of expenses](https://aibio.space/news/lisata-kuva-labs-delay-tender-offer-start-may-29-kuva-pay-up-1-1/) |
| 2026-05-04 | Aura Biosciences [AURA](https://aibio.space/companies/aura-biosciences/) | Other deal | [Aura Biosciences agrees to repurchase Matrix Capital's 6,922,870 shares at $5.64 offering price](https://aibio.space/news/aura-biosciences-agrees-repurchase-matrix-capitals-6-922-870-shares-5/) |
| 2026-05-04 | Gyre Therapeutics [GYRE](https://aibio.space/companies/gyre-therapeutics/) | Other deal | [Gyre Therapeutics completes all-stock acquisition of Cullgen valued at about $300 million](https://aibio.space/news/gyre-therapeutics-completes-all-stock-acquisition-cullgen-valued-about/) |
| 2026-05-03 | Rallybio [RLYB](https://aibio.space/companies/rallybio/) | Deal ended | [Rallybio to receive $50,000,000 fee after Candid ends merger](https://aibio.space/news/rallybio-receive-50-000-000-fee-after-candid-ends-merger/) |
| 2026-05-01 | Shuttle Pharmaceuticals Holdings [SHPH](https://aibio.space/companies/shuttle-pharmaceuticals/) | Other deal | [Shuttle Pharmaceuticals agrees to merge with United Dogecoin](https://aibio.space/news/shuttle-pharmaceuticals-agrees-merge-united-dogecoin/) |
| 2026-05-01 | Senti Biosciences Holdings [SNTI](https://aibio.space/companies/senti-biosciences/) | Deal ended | [Senti Biosciences agrees to sell $10.0 million of secured convertible notes to Celadon affiliate](https://aibio.space/news/senti-biosciences-agrees-sell-10-0-million-secured-convertible-notes/) |
| 2026-04-30 | Perrigo Company [PRGO](https://aibio.space/companies/perrigo/) | Asset sale or purchase | [Perrigo completes sale of Dermacosmetics business to Karo for €305.6 million in cash](https://aibio.space/news/perrigo-completes-sale-dermacosmetics-business-karo-305-6-million-cash/) |
| 2026-04-28 | Avalo Therapeutics [AVTX](https://aibio.space/companies/avalo-therapeutics/) | Other deal | [Avalo Therapeutics agrees to pay $2.25 million for option on $15 million AlmataBio milestone](https://aibio.space/news/avalo-therapeutics-agrees-pay-2-25-million-option-15-million-almatabio/) |
| 2026-04-27 | Ligand Pharmaceuticals [LGND](https://aibio.space/companies/ligand-pharmaceuticals/) | Takeover | [Ligand Pharmaceuticals signs merger agreement to acquire XOMA Royalty for $39.00 per share in cash](https://aibio.space/news/ligand-pharmaceuticals-signs-merger-agreement-acquire-xoma-royalty-39/) |
| 2026-04-27 | Organon & Co. [OGN](https://aibio.space/companies/organon/) | Other deal | [Organon agrees to be acquired by Sun Pharma for $14.00 per share in cash](https://aibio.space/news/organon-agrees-acquired-sun-pharma-14-00-share-cash/) |
| 2026-04-24 | Telomir Pharmaceuticals [TELO](https://aibio.space/companies/telomir-pharmaceuticals/) | Other deal | [Telomir Pharmaceuticals completes acquisition of TELI Pharmaceuticals for 34,389,710 shares](https://aibio.space/news/telomir-pharmaceuticals-completes-acquisition-teli-pharmaceuticals-34/) |
| 2026-04-22 | Obsidian Therapeutics [OBX](https://aibio.space/companies/obsidian-therapeutics/) | Other deal | [Galera and Obsidian Therapeutics merger moves forward with Gazelle Parent S-4](https://aibio.space/news/galera-obsidian-therapeutics-merger-moves-forward-gazelle-parent-s-4/) |
| 2026-04-20 | First Tracks Biotherapeutics [TRAX](https://aibio.space/companies/first-tracks-biotherapeutics/) | Other deal | [First Tracks Biotherapeutics begins Nasdaq trading after AnaptysBio spin-off](https://aibio.space/news/first-tracks-biotherapeutics-begins-nasdaq-trading-after-anaptysbio/) |
| 2026-04-20 | AnaptysBio [ANAB](https://aibio.space/companies/anaptysbio/) | Other deal | [AnaptysBio completes spin-off of First Tracks Biotherapeutics, keeps royalty business](https://aibio.space/news/anaptysbio-completes-spin-off-first-tracks-biotherapeutics/) |
| 2026-04-20 | AnaptysBio, First Tracks Biotherapeutics [ANAB](https://aibio.space/companies/anaptysbio/)[TRAX](https://aibio.space/companies/first-tracks-biotherapeutics/) | Other deal | [AnaptysBio completes spin-off of First Tracks Biotherapeutics](https://aibio.space/news/anaptysbio-completes-spin-off-first-tracks-biotherapeutics/) |
| 2026-04-20 | First Tracks Biotherapeutics [TRAX](https://aibio.space/companies/first-tracks-biotherapeutics/) | Other deal | [First Tracks Biotherapeutics begins Nasdaq trading as TRAX with $180 million in cash](https://aibio.space/news/first-tracks-biotherapeutics-begins-nasdaq-trading-trax-180-million/) |
| 2026-04-16 | MeiraGTx Holdings [MGTX](https://aibio.space/companies/meiragtx/) | Asset sale or purchase | [MeiraGTx buys XLRP gene therapy rights from Janssen for $25,000,000 upfront](https://aibio.space/news/meiragtx-buys-xlrp-gene-therapy-rights-janssen-25-000-000-upfront/) |
| 2026-04-16 | MeiraGTx Holdings [MGTX](https://aibio.space/companies/meiragtx/) | Takeover | [MeiraGTx agrees to buy bota-vec from Johnson & Johnson for $25 million upfront](https://aibio.space/news/meiragtx-agrees-buy-bota-vec-johnson-johnson-25-million-upfront/) |
| 2026-04-15 | Wave Life Sciences [WVE](https://aibio.space/companies/wave-life-sciences/) | Other deal | [Wave Life Sciences plans to move its parent company from Singapore to Delaware](https://aibio.space/news/wave-life-sciences-plans-move-parent-company-singapore-delaware/) |
| 2026-04-07 | Supernus Pharmaceuticals [SUPN](https://aibio.space/companies/supernus-pharmaceuticals/) | Other deal | [Supernus acquires Navitor's NV-5138 assets for a study pledge and up to $350 million in milestones](https://aibio.space/news/supernus-acquires-navitors-nv-5138-assets-study-pledge-up-350-million/) |
| 2026-04-07 | Northwest Biotherapeutics [NWBO](https://aibio.space/companies/northwest-biotherapeutics/) | Other deal | [Northwest Biotherapeutics reports October 2025 closing of Advent BioServices purchase](https://aibio.space/news/northwest-biotherapeutics-reports-october-2025-closing-advent/) |
| 2026-04-03 | Lisata Therapeutics [LSTA](https://aibio.space/companies/lisata-therapeutics/) | Takeover | [Lisata and Kuva Labs push back tender offer start to April 13, 2026](https://aibio.space/news/lisata-kuva-labs-push-back-tender-offer-start-april-13-2026/) |
| 2026-04-03 | Aurinia Pharmaceuticals [AUPH](https://aibio.space/companies/aurinia-pharmaceuticals/) | Takeover | [Aurinia unit agrees to acquire Kezar Life Sciences in tender offer at $6.955 per share plus a CVR](https://aibio.space/news/aurinia-unit-agrees-acquire-kezar-life-sciences-tender-offer-6-955/) |
| 2026-04-01 | Korsana Biosciences [KRSA](https://aibio.space/companies/korsana-biosciences/) | Other deal | [Cyclerion (now Korsana Biosciences) agrees to all-stock merger with Korsana, $380 million financing](https://aibio.space/news/cyclerion-now-korsana-biosciences-agrees-all-stock-merger-korsana-380/) |
| 2026-03-31 | Oramed Pharmaceuticals [ORMP](https://aibio.space/companies/oramed-pharmaceuticals/) | Asset sale or purchase | [Oramed closes Oratech sale to Lifeward for shares, warrants and revenue share](https://aibio.space/news/oramed-closes-oratech-sale-lifeward-shares-warrants-revenue-share/) |
| 2026-03-31 | SCYNEXIS [SCYX](https://aibio.space/companies/scynexis/) | Other deal | [SCYNEXIS acquires Poxel's PXL-770 for $8,000,000 upfront and up to $188,000,000 in milestones](https://aibio.space/news/scynexis-acquires-poxels-pxl-770-8-000-000-upfront-up-188-000-000/) |
| 2026-03-24 | Indaptus Therapeutics [INDP](https://aibio.space/companies/indaptus-therapeutics/) | Other deal | [Indaptus Therapeutics reports change in control as Lazar sells preferred stock for $11,200,000](https://aibio.space/news/indaptus-therapeutics-reports-change-control-lazar-sells-preferred/) |
| 2026-03-24 | Lakefront Biotherapeutics [LKFT](https://aibio.space/companies/lakefront-biotherapeutics/) | Other deal | [Galapagos (now Lakefront Biotherapeutics) in advanced talks with Gilead on Ouro program](https://aibio.space/news/galapagos-now-lakefront-biotherapeutics-advanced-talks-gilead-ouro/) |
| 2026-03-12 | SciSparc, NeuroThera Labs [SPRC](https://aibio.space/companies/scisparc/)[NTLX](https://aibio.space/companies/neurothera-labs/) | Other deal | [SciSparc unit NeuroThera Labs to buy 54.01% of CliniQuantum for shares](https://aibio.space/news/scisparc-unit-neurothera-labs-buy-54-01-percent-cliniquantum-shares/) |
| 2026-02-27 | Indaptus Therapeutics [INDP](https://aibio.space/companies/indaptus-therapeutics/) | Other deal | [Indaptus stockholders approve preferred stock conversion and reverse split range](https://aibio.space/news/indaptus-stockholders-approve-preferred-stock-conversion-reverse-split/) |
| 2026-02-27 | Atrium Therapeutics [RNA](https://aibio.space/companies/atrium-therapeutics/) | Other deal | [Atrium Therapeutics completes spin-off from Avidity Biosciences, starts trading on Nasdaq as RNA](https://aibio.space/news/atrium-therapeutics-completes-spin-off-avidity-biosciences-starts/) |
| 2026-02-26 | Atrium Therapeutics [RNA](https://aibio.space/companies/atrium-therapeutics/) | Deal ended | [Atrium Therapeutics spin-off from Avidity to give holders one share per ten](https://aibio.space/news/atrium-therapeutics-spin-off-avidity-give-holders-one-share-ten/) |
| 2026-02-18 | Faeth Therapeutics [FTH](https://aibio.space/companies/faeth-therapeutics/) | Other deal | [Sensei Biotherapeutics acquires Faeth Therapeutics, agrees to $200 million private placement](https://aibio.space/news/sensei-biotherapeutics-acquires-faeth-therapeutics-agrees-200-million/) |
| 2026-02-13 | Nutriband [NTRB](https://aibio.space/companies/nutriband/) | Asset sale or purchase | [Nutriband terminates planned $5 million sale of Pocono unit](https://aibio.space/news/nutriband-terminates-planned-5-million-sale-pocono-unit/) |
| 2026-01-26 | Indivior Pharmaceuticals [INDV](https://aibio.space/companies/indivior-pharmaceuticals/) | Other deal | [Indivior PLC (now Indivior Pharmaceuticals, Inc.) completes U.S. domestication](https://aibio.space/news/indivior-plc-now-indivior-pharmaceuticals-inc-completes/) |
| 2026-01-16 | Agenus [AGEN](https://aibio.space/companies/agenus/) | Deal ended | [Agenus completes $75.0 million manufacturing asset sale to Zydus and $16.0 million stock sale](https://aibio.space/news/agenus-completes-75-0-million-manufacturing-asset-sale-zydus-16-0/) |
| 2025-12-18 | SL Science Holding [SLBT](https://aibio.space/companies/sl-science/) | Other deal | [SL Science Holding files F-4 for Horizon Space Acquisition II and SL BIO merger](https://aibio.space/news/sl-science-holding-files-f-4-horizon-space-acquisition-ii-sl-bio/) |
| 2025-12-11 | Valion Bio [VBIO](https://aibio.space/companies/valion-bio/) | Asset sale or purchase | [Tivic Health Systems (now Valion Bio) buys Scorpius CDMO assets for $16,253,147.10](https://aibio.space/news/tivic-health-systems-now-valion-bio-buys-scorpius-cdmo-assets-16-253/) |
| 2025-12-05 | Natera [NTRA](https://aibio.space/companies/natera/) | Other deal | [Natera closes Foresight Diagnostics acquisition, agrees to issue 1,127,982 shares](https://aibio.space/news/natera-closes-foresight-diagnostics-acquisition-agrees-issue-1-127-982/) |
| 2025-12-04 | Baxter International [BAX](https://aibio.space/companies/baxter-international/) | Takeover | [Baxter closes three-series senior notes offering with about $1.99 billion in net proceeds](https://aibio.space/news/baxter-closes-three-series-senior-notes-offering-about-1-99-billion/) |
| 2025-12-01 | Omeros [OMER](https://aibio.space/companies/omeros/) | Other deal | [Omeros closes zaltenibart sale to Novo Nordisk, receives $240.0 million and repays term loan](https://aibio.space/news/omeros-closes-zaltenibart-sale-novo-nordisk-receives-240-0-million/) |
| 2025-12-01 | Q32 Bio, Akebia Therapeutics [QTTB](https://aibio.space/companies/q32-bio/)[AKBA](https://aibio.space/companies/akebia-therapeutics/) | Other deal | [Q32 Bio sells ADX-097 to Akebia Therapeutics for $7.0 million upfront](https://aibio.space/news/q32-bio-sells-adx-097-akebia-therapeutics-7-0-million-upfront/) |
| 2025-11-20 | Abbott Laboratories [ABT](https://aibio.space/companies/abbott-laboratories/) | Takeover | [Abbott agrees to acquire Exact Sciences for $105 per share in cash, about $21 billion](https://aibio.space/news/abbott-agrees-acquire-exact-sciences-105-share-cash-about-21-billion/) |
| 2025-11-18 | Harrow [HROW](https://aibio.space/companies/harrow/) | Other deal | [Harrow completes Melt Pharmaceuticals acquisition with approximately $4.3 million paid at closing](https://aibio.space/news/harrow-completes-melt-pharmaceuticals-acquisition-approximately-4-3/) |
| 2025-11-18 | Bristol-Myers Squibb [BMY](https://aibio.space/companies/bristol-myers-squibb/) | Takeover | [Bristol Myers Squibb amends cash tender offers and sets early settlement for November 20](https://aibio.space/news/bristol-myers-squibb-amends-cash-tender-offers-sets-early-settlement/) |
| 2025-11-14 | IGC Pharma [IGC](https://aibio.space/companies/igc-pharma/) | Other deal | [IGC Pharma subsidiary closes Vancouver facility asset sale valued at about $2.7 million](https://aibio.space/news/igc-pharma-subsidiary-closes-vancouver-facility-asset-sale-valued/) |
| 2025-11-14 | IGC Pharma [IGC](https://aibio.space/companies/igc-pharma/) | Other deal | [IGC Pharma unit sold Vancouver facility assets for supply rights, not cash](https://aibio.space/news/igc-pharma-unit-sold-vancouver-facility-assets-supply-rights-not-cash/) |
| 2025-11-10 | Damora Therapeutics [DMRA](https://aibio.space/companies/damora-therapeutics/) | Asset sale or purchase | [Galecto (now Damora Therapeutics) buys Damora, agrees to about $285 million private placement](https://aibio.space/news/galecto-now-damora-therapeutics-buys-damora-agrees-about-285-million/) |
| 2025-11-07 | Biofrontera [BFRI](https://aibio.space/companies/biofrontera-bfri/) | Deal ended | [Biofrontera sells Xepi cream assets to Pelthos Therapeutics, gets $3 million at closing](https://aibio.space/news/biofrontera-sells-xepi-cream-assets-pelthos-therapeutics-gets-3/) |
| 2025-11-04 | Absci [ABSI](https://aibio.space/companies/absci/) | Other deal | [Absci and Totient sellers agree final milestone payout under 2021 merger agreement](https://aibio.space/news/absci-totient-sellers-agree-final-milestone-payout-under-2021-merger/) |
| 2025-10-31 | Calidi Biotherapeutics [CLDI](https://aibio.space/companies/calidi-biotherapeutics/) | Other deal | [Calidi Biotherapeutics sells 75% Nova Cell stake for $6,000,000, mostly deferred and contingent](https://aibio.space/news/calidi-biotherapeutics-sells-75-percent-nova-cell-stake-6-000-000/) |
| 2025-10-24 | Biofrontera [BFRI](https://aibio.space/companies/biofrontera-bfri/) | Other deal | [Biofrontera Inc. closes purchase of U.S. Ameluz and RhodoLED rights, sells $2.5 million preferred](https://aibio.space/news/biofrontera-inc-closes-purchase-u-s-ameluz-rhodoled-rights-sells-2-5/) |
| 2025-10-22 | Alkermes [ALKS](https://aibio.space/companies/alkermes/) | Takeover | [Alkermes agrees to buy Avadel for $18.50 a share plus CVR, with JPMorgan bridge loan](https://aibio.space/news/alkermes-agrees-buy-avadel-18-50-share-plus-cvr-jpmorgan-bridge-loan/) |
| 2025-10-20 | BioNTech [BNTX](https://aibio.space/companies/biontech/) | Other deal | [BioNTech opens exchange offer for CureVac with 15,061,575 new ADSs registered](https://aibio.space/news/biontech-opens-exchange-offer-curevac-15-061-575-new-adss-registered/) |
| 2025-10-20 | Keros Therapeutics [KROS](https://aibio.space/companies/keros-therapeutics/) | Takeover | [Keros Therapeutics starts tender offer for up to 10,950,165 shares at $17.75](https://aibio.space/news/keros-therapeutics-starts-tender-offer-up-10-950-165-shares-17-75/) |
| 2025-10-15 | Keros Therapeutics [KROS](https://aibio.space/companies/keros-therapeutics/) | Takeover | [Keros Therapeutics to repurchase 10,176,595 shares for about $181 million, plans tender offer](https://aibio.space/news/keros-therapeutics-repurchase-10-176-595-shares-about-181-million/) |
| 2025-10-15 | Keros Therapeutics [KROS](https://aibio.space/companies/keros-therapeutics/) | Takeover | [Keros agrees to buy back ADAR1 and Pontifax shares at $17.75, plans tender offer](https://aibio.space/news/keros-agrees-buy-back-adar1-pontifax-shares-17-75-plans-tender-offer/) |
| 2025-10-08 | TransCode Therapeutics [RNAZ](https://aibio.space/companies/transcode-therapeutics/) | Takeover | [TransCode agrees to buy Polynoma and sell CK Life Sciences $25 million of preferred stock](https://aibio.space/news/transcode-agrees-buy-polynoma-sell-ck-life-sciences-25-million/) |
| 2025-10-07 | Elutia [ELUT](https://aibio.space/companies/elutia/) | Other deal | [Elutia closes CIED business sale to Boston Scientific, puts $8 million in escrow, repays SWK loan](https://aibio.space/news/elutia-closes-cied-business-sale-boston-scientific-puts-8-million/) |
| 2025-10-07 | Elutia, BOSTON SCIENTIFIC CORP [ELUT](https://aibio.space/companies/elutia/)[BSX](https://aibio.space/companies/boston-scientific/) | Asset sale or purchase | [Elutia closes $88 million sale of BioEnvelope business to Boston Scientific](https://aibio.space/news/elutia-closes-88-million-sale-bioenvelope-business-boston-scientific/) |
| 2025-10-06 | GridAI Technologies [GRDX](https://aibio.space/companies/gridai-technologies/) | Other deal | [Entero Therapeutics (now GridAI Technologies) acquires GRID AI, whose holders get 82.5%](https://aibio.space/news/entero-therapeutics-now-gridai-technologies-acquires-grid-ai-whose/) |
| 2025-10-03 | Halozyme Therapeutics [HALO](https://aibio.space/companies/halozyme-therapeutics/) | Takeover | [Halozyme signs merger agreement to acquire Elektrofi for $750 million in cash upfront](https://aibio.space/news/halozyme-signs-merger-agreement-acquire-elektrofi-750-million-cash/) |
| 2025-09-30 | MIRA Pharmaceuticals [MIRA](https://aibio.space/companies/mira-pharmaceuticals/) | Other deal | [MIRA Pharmaceuticals closes SKNY acquisition in all-stock deal](https://aibio.space/news/mira-pharmaceuticals-closes-skny-acquisition-all-stock-deal/) |
| 2025-09-12 | Traws Pharma [TRAW](https://aibio.space/companies/traws-pharma/) | Asset sale or purchase | [Traws Pharma buys antiviral compound assets from related party Viriom for $2,350,000 cash](https://aibio.space/news/traws-pharma-buys-antiviral-compound-assets-related-party-viriom-2-350/) |
| 2025-09-12 | NRX Pharmaceuticals [NRXP](https://aibio.space/companies/nrx-pharmaceuticals/) | Other deal | [NRx Pharmaceuticals completes acquisition of Dura Medical clinics through HOPE unit](https://aibio.space/news/nrx-pharmaceuticals-completes-acquisition-dura-medical-clinics-through/) |
| 2025-09-12 | Traws Pharma [TRAW](https://aibio.space/companies/traws-pharma/) | Asset sale or purchase | [Traws Pharma buys antiviral assets from Viriom for $2,350,000 in related-party deal](https://aibio.space/news/traws-pharma-buys-antiviral-assets-viriom-2-350-000-related-party-deal/) |
| 2025-09-11 | Bausch Health Companies [BHC](https://aibio.space/companies/bausch-health-companies/) | Takeover | [Bausch Health completes DURECT acquisition after tender offer draws about 62% of shares](https://aibio.space/news/bausch-health-completes-durect-acquisition-after-tender-offer-draws/) |
| 2025-09-08 | Pharvaris [PHVS](https://aibio.space/companies/pharvaris-n-v/) | Other deal | [Pharvaris signs registration rights agreement with General Atlantic PH B.V.](https://aibio.space/news/pharvaris-signs-registration-rights-agreement-general-atlantic-ph/) |
| 2025-09-05 | Kyntra Bio [KYNB](https://aibio.space/companies/kyntra-bio/) | Other deal | [FibroGen (now Kyntra Bio) completes $220 million China unit sale to AstraZeneca](https://aibio.space/news/fibrogen-now-kyntra-bio-completes-220-million-china-unit-sale/) |
| 2025-09-05 | PharmaCyte Biotech [PMCB](https://aibio.space/companies/pharmacyte-biotech/) | Other deal | [PharmaCyte Biotech adds $3 million to its stake in TNF Pharmaceuticals](https://aibio.space/news/pharmacyte-biotech-adds-3-million-stake-tnf-pharmaceuticals/) |
| 2025-09-02 | Medicus Pharma [MDCX](https://aibio.space/companies/medicus-pharma/) | Other deal | [Medicus Pharma completes Antev acquisition for about US$3.0 million cash and 1,603,164 shares](https://aibio.space/news/medicus-pharma-completes-antev-acquisition-about-us-3-0-million-cash-1/) |
| 2025-09-02 | CorMedix [CRMD](https://aibio.space/companies/cormedix/) | Other deal | [CorMedix completes Melinta Therapeutics acquisition for $300 million in upfront consideration](https://aibio.space/news/cormedix-completes-melinta-therapeutics-acquisition-300-million/) |
| 2025-09-02 | Zenas BioPharma, Royalty Pharma [ZBIO](https://aibio.space/companies/zenas-biopharma/)[RPRX](https://aibio.space/companies/royalty-pharma/) | Other deal | [Zenas BioPharma signs Royalty Pharma funding deal worth up to $300 million](https://aibio.space/news/zenas-biopharma-signs-royalty-pharma-funding-deal-worth-up-300-million/) |
| 2025-08-26 | Evofem Biosciences [EVFM](https://aibio.space/companies/evofem-biosciences/) | Other deal | [Evofem signs sixth amendment to Aditxt merger agreement](https://aibio.space/news/evofem-signs-sixth-amendment-aditxt-merger-agreement/) |
| 2025-08-15 | Heron Therapeutics [HRTX](https://aibio.space/companies/heron-therapeutics/) | Other deal | [Heron Therapeutics adopts rights plan with 4.99% trigger to protect tax losses](https://aibio.space/news/heron-therapeutics-adopts-rights-plan-4-99-percent-trigger-protect-tax/) |
| 2025-08-15 | Heron Therapeutics [HRTX](https://aibio.space/companies/heron-therapeutics/) | Other deal | [Heron Therapeutics adopts rights plan to protect $1.37 billion of tax losses](https://aibio.space/news/heron-therapeutics-adopts-rights-plan-protect-1-37-billion-tax-losses/) |
| 2025-08-13 | BridgeBio Oncology Therapeutics [BBOT](https://aibio.space/companies/bridgebio-oncology-therapeutics/) | Other deal | [Helix Acquisition Corp. II (now BridgeBio Oncology Therapeutics) completes business combination](https://aibio.space/news/helix-acquisition-corp-ii-now-bridgebio-oncology-therapeutics/) |
| 2025-08-07 | PTC Therapeutics [PTCT](https://aibio.space/companies/ptc-therapeutics/) | Other deal | [PTC Therapeutics pays about $225.0 million to cancel Censa sepiapterin sales payment rights](https://aibio.space/news/ptc-therapeutics-pays-about-225-0-million-cancel-censa-sales-payments/) |
| 2025-08-07 | CorMedix [CRMD](https://aibio.space/companies/cormedix/) | Other deal | [CorMedix to buy Melinta Therapeutics, closing targeted as early as September 1](https://aibio.space/news/cormedix-buy-melinta-therapeutics-closing-targeted-early-september-1/) |
| 2025-08-07 | PTC Therapeutics [PTCT](https://aibio.space/companies/ptc-therapeutics/) | Other deal | [PTC Therapeutics pays about $225.0 million to cancel Censa sales payments](https://aibio.space/news/ptc-therapeutics-pays-about-225-0-million-cancel-censa-sales-payments/) |
| 2025-08-01 | NeOnc Technologies Holdings [NTHI](https://aibio.space/companies/neonc-technologies/) | Deal ended | [NeOnc Technologies signs up to $50 million investment deal with Quazar at $25 per share](https://aibio.space/news/neonc-technologies-signs-up-50-million-investment-deal-quazar-25-share/) |
| 2025-07-31 | Supernus Pharmaceuticals [SUPN](https://aibio.space/companies/supernus-pharmaceuticals/) | Takeover | [Supernus completes Sage Therapeutics acquisition after tender offer, $8.50 per share plus CVR](https://aibio.space/news/supernus-completes-sage-therapeutics-acquisition-after-tender-offer-8/) |
| 2025-07-31 | Adaptimmune Therapeutics [ADAPY](https://aibio.space/companies/adaptimmune-therapeutics/) | Other deal | [Adaptimmune sells cell therapy assets to US WorldMeds for $55 million upfront](https://aibio.space/news/adaptimmune-sells-cell-therapy-assets-us-worldmeds-55-million-upfront/) |
| 2025-07-31 | Veraxa Biotech [VRXA](https://aibio.space/companies/veraxa-biotech/) | Other deal | [Veraxa Biotech Holding AG (now Veraxa Biotech AG) files F-4 for Voyager SPAC deal](https://aibio.space/news/veraxa-biotech-holding-ag-now-veraxa-biotech-ag-files-f-4-voyager-spac/) |
| 2025-07-29 | ImageneBio [IMA](https://aibio.space/companies/imagenebio/) | Other deal | [Ikena Oncology (now ImageneBio) completes Inmagene merger, issues contingent value rights](https://aibio.space/news/ikena-oncology-now-imagenebio-completes-inmagene-merger-issues/) |
| 2025-07-29 | ImageneBio [IMA](https://aibio.space/companies/imagenebio/) | Other deal | [ImageneBio says Ikena Oncology and Imagene merger completed in July 2025](https://aibio.space/news/imagenebio-says-ikena-oncology-imagene-merger-completed-july-2025/) |
| 2025-07-22 | Lantheus Holdings [LNTH](https://aibio.space/companies/lantheus/) | Other deal | [Lantheus completes Life Molecular Imaging acquisition with $350 million upfront payment](https://aibio.space/news/lantheus-completes-life-molecular-imaging-acquisition-350-million/) |
| 2025-07-17 | NovaBridge Biosciences [NBP](https://aibio.space/companies/novabridge-biosciences/) | Other deal | [I-Mab (now NovaBridge Biosciences) to buy Bridge Health Biotech for $1.8 million upfront](https://aibio.space/news/i-mab-now-novabridge-biosciences-buy-bridge-health-biotech-1-8-million/) |
| 2025-07-16 | Oncopeptides AB [ONCO](https://aibio.space/companies/oncopeptides/) | Other deal | [Onconetix signs merger deal with Ocuvex; Ocuvex holders would own 90%](https://aibio.space/news/onconetix-signs-merger-deal-ocuvex-ocuvex-holders-would-own-90-percent/) |
| 2025-07-11 | BridgeBio Oncology Therapeutics, BridgeBio Pharma [BBOT](https://aibio.space/companies/bridgebio-oncology-therapeutics/)[BBIO](https://aibio.space/companies/bridgebio-pharma/) | Other deal | [Helix Acquisition Corp. II (now BridgeBio Oncology Therapeutics) says S-4 is effective, vote set for August 4](https://aibio.space/news/helix-acquisition-corp-ii-now-bridgebio-oncology-therapeutics-says-s-4/) |
| 2025-07-11 | Semnur Pharmaceuticals [SMNR](https://aibio.space/companies/semnur-pharmaceuticals/) | Deal ended | [Denali Capital (now Semnur Pharmaceuticals) extends SPAC deadline to August 11, 2025](https://aibio.space/news/denali-capital-now-semnur-pharmaceuticals-extends-spac-deadline-august/) |
| 2025-07-08 | Rallybio [RLYB](https://aibio.space/companies/rallybio/) | Other deal | [Rallybio sells 50% stake in ENPP1 joint venture to Recursion for cash and shares](https://aibio.space/news/rallybio-sells-50-percent-stake-enpp1-joint-venture-recursion-cash/) |
| 2025-07-08 | Rallybio [RLYB](https://aibio.space/companies/rallybio/) | Other deal | [Rallybio sells ENPP1 joint venture stake to Recursion for initial $7,500,000 in stock](https://aibio.space/news/rallybio-sells-enpp1-joint-venture-stake-recursion-initial-7-500-000/) |
| 2025-07-02 | Pelthos Therapeutics [PTHS](https://aibio.space/companies/pelthos-therapeutics/) | Other deal | [Channel Therapeutics (now Pelthos Therapeutics) closes merger and $50.1 million private placement](https://aibio.space/news/channel-therapeutics-now-pelthos-therapeutics-closes-merger-50-1/) |
| 2025-07-02 | Abeona Therapeutics [ABEO](https://aibio.space/companies/abeona-therapeutics/) | Asset sale or purchase | [Abeona Therapeutics closes $155 million sale of priority review voucher](https://aibio.space/news/abeona-therapeutics-closes-155-million-sale-priority-review-voucher/) |
| 2025-07-02 | Pelthos Therapeutics [PTHS](https://aibio.space/companies/pelthos-therapeutics/) | Other deal | [Channel Therapeutics (now Pelthos) sets 10-for-one reverse split ahead of merger](https://aibio.space/news/channel-therapeutics-now-pelthos-sets-10-one-reverse-split-ahead/) |
| 2025-07-01 | ImageneBio [IMA](https://aibio.space/companies/imagenebio/) | Other deal | [Ikena Oncology (now ImageneBio) files merger partner Inmagene's Phase 2b trial start](https://aibio.space/news/ikena-oncology-now-imagenebio-files-merger-partner-inmagenes-phase-2b/) |
| 2025-06-30 | TuHURA Biosciences [HURA](https://aibio.space/companies/tuhura-biosciences/) | Other deal | [TuHURA Biosciences completes Kineta acquisition, paying 0.185298 TuHURA share per Kineta share](https://aibio.space/news/tuhura-biosciences-completes-kineta-acquisition-paying-0-185298-tuhura/) |
| 2025-06-30 | TuHURA Biosciences [HURA](https://aibio.space/companies/tuhura-biosciences/) | Other deal | [TuHURA Biosciences completes acquisition of Kineta in all-stock deal](https://aibio.space/news/tuhura-biosciences-completes-acquisition-kineta-all-stock-deal/) |
| 2025-06-30 | Medicus Pharma [MDCX](https://aibio.space/companies/medicus-pharma/) | Takeover | [Medicus Pharma agrees to buy Antev for 2,666,600 shares plus up to US$65 million](https://aibio.space/news/medicus-pharma-agrees-buy-antev-2-666-600-shares-plus-up-us-65-million/) |
| 2025-06-23 | Impact BioMedical [IBO](https://aibio.space/companies/impact-biomedical/) | Reverse merger | [Impact BioMedical signs reverse merger agreement with Dr Ashleys Limited](https://aibio.space/news/impact-biomedical-signs-reverse-merger-agreement-dr-ashleys-limited/) |
| 2025-06-23 | Impact BioMedical [IBO](https://aibio.space/companies/impact-biomedical/) | Reverse merger | [Impact BioMedical agrees to reverse merger with Hong Kong drugmaker Dr Ashleys](https://aibio.space/news/impact-biomedical-agrees-reverse-merger-hong-kong-drugmaker-dr-ashleys/) |
| 2025-06-23 | Ocugen, Carisma Therapeutics [OCGN](https://aibio.space/companies/ocugen/)[CARM](https://aibio.space/companies/carisma-therapeutics/) | Other deal | [Ocugen unit OrthoCellix to merge with Carisma alongside planned $25.0 million financing](https://aibio.space/news/ocugen-unit-orthocellix-merge-carisma-alongside-planned-25-0-million/) |
| 2025-06-23 | Viskase Holdings [VISK](https://aibio.space/companies/viskase/) | Other deal | [Enzon Pharmaceuticals (now Viskase Holdings) agrees all-stock merger with Viskase](https://aibio.space/news/enzon-pharmaceuticals-now-viskase-holdings-agrees-all-stock-merger/) |
| 2025-06-18 | Crescent Biopharma [CBIO](https://aibio.space/companies/crescent-biopharma/) | Other deal | [GlycoMimetics (now Crescent Biopharma) completes merger and $200 million private financing](https://aibio.space/news/glycomimetics-now-crescent-biopharma-completes-merger-200-million/) |
| 2025-06-11 | Decoy Therapeutics [DCOY](https://aibio.space/companies/decoy-therapeutics/) | Other deal | [Salarius (now Decoy Therapeutics) cuts its valuation to $2.31 million in merger deal](https://aibio.space/news/salarius-now-decoy-therapeutics-cuts-valuation-2-31-million-merger/) |
| 2025-06-06 | Aytu BioPharma [AYTU](https://aibio.space/companies/aytu-biopharma/) | Other deal | [Aytu BioPharma signs EXXUA commercialization deal with Fabre-Kramer, pays $3,000,000 upfront](https://aibio.space/news/aytu-biopharma-signs-exxua-commercialization-deal-fabre-kramer-pays-3/) |
| 2025-06-06 | Aytu BioPharma [AYTU](https://aibio.space/companies/aytu-biopharma/) | Other deal | [Aytu BioPharma pays $3,000,000 upfront for U.S. rights to depression drug EXXUA](https://aibio.space/news/aytu-biopharma-pays-3-000-000-upfront-u-s-rights-depression-drug-exxua/) |
| 2025-06-05 | Fortress Biotech [FBIO](https://aibio.space/companies/fortress-biotech/) | Other deal | [Fortress Biotech to receive about $28.0 million as Checkpoint merger with Sun Pharma closes](https://aibio.space/news/fortress-biotech-receive-about-28-0-million-checkpoint-sale-sun-pharma/) |
| 2025-06-05 | Fortress Biotech [FBIO](https://aibio.space/companies/fortress-biotech/) | Asset sale or purchase | [Fortress Biotech to receive about $28.0 million as Checkpoint sale to Sun Pharma closes](https://aibio.space/news/fortress-biotech-receive-about-28-0-million-checkpoint-sale-sun-pharma/) |
| 2025-06-03 | Alto Neuroscience [ANRO](https://aibio.space/companies/alto-neuroscience/) | Asset sale or purchase | [Alto Neuroscience buys depression drug candidates from Chase Therapeutics, pays $1,750,000 upfront](https://aibio.space/news/alto-neuroscience-buys-depression-drug-candidates-chase-therapeutics/) |
| 2025-05-21 | Alumis [ALMS](https://aibio.space/companies/alumis/) | Deal ended | [Alumis completes ACELYRIN merger at 0.4814 Alumis shares per ACELYRIN share](https://aibio.space/news/alumis-completes-acelyrin-merger-0-4814-alumis-shares-acelyrin-share/) |
| 2025-05-21 | Alumis [ALMS](https://aibio.space/companies/alumis/) | Other deal | [Alumis completes merger with ACELYRIN at 0.4814 shares per ACELYRIN share](https://aibio.space/news/alumis-completes-merger-acelyrin-0-4814-shares-acelyrin-share/) |
| 2025-05-19 | Royalty Pharma [RPRX](https://aibio.space/companies/royalty-pharma/) | Other deal | [Royalty Pharma completes acquisition of RP LLC for $200,000,000 cash and 24,530,266 Class E shares](https://aibio.space/news/royalty-pharma-completes-acquisition-rp-llc-200-000-000-cash-24-530/) |
| 2025-05-19 | Protagenic Therapeutics [PTIX](https://aibio.space/companies/protagenic-therapeutics/) | Other deal | [Protagenic Therapeutics combines with Phytanix Bio in all-stock deal](https://aibio.space/news/protagenic-therapeutics-combines-phytanix-bio-all-stock-deal/) |
| 2025-05-15 | Pulmatrix [PULM](https://aibio.space/companies/pulmatrix/) | Asset sale or purchase | [Pulmatrix says Cullgen merger registration is effective, plans to divest assets](https://aibio.space/news/pulmatrix-says-cullgen-merger-registration-effective-plans-divest/) |
| 2025-05-15 | Pulmatrix [PULM](https://aibio.space/companies/pulmatrix/) | Other deal | [Pulmatrix says Cullgen merger filing is effective, expects June 2025 close](https://aibio.space/news/pulmatrix-says-cullgen-merger-filing-effective-expects-june-2025-close/) |
| 2025-05-14 | Jade Biosciences [JBIO](https://aibio.space/companies/jade-biosciences/) | Other deal | [Jade Biosciences files Q1 financials after Aerovate merger and $334.2 million financing](https://aibio.space/news/jade-biosciences-files-q1-financials-after-aerovate-merger-334-2/) |
| 2025-05-14 | Jade Biosciences [JBIO](https://aibio.space/companies/jade-biosciences/) | Other deal | [Jade Biosciences (formerly Aerovate) details $334.2 million pre-merger financing](https://aibio.space/news/jade-biosciences-formerly-aerovate-details-334-2-million-pre-merger/) |
| 2025-05-01 | Jade Biosciences [JBIO](https://aibio.space/companies/jade-biosciences/) | Other deal | [Aerovate Therapeutics (now Jade Biosciences) completes merger and private placement](https://aibio.space/news/aerovate-therapeutics-now-jade-biosciences-completes-merger-private/) |
| 2025-04-30 | Avenue Therapeutics [ATXI](https://aibio.space/companies/avenue-therapeutics/) | Deal ended | [Avenue Therapeutics ends AJ201 license and transfers program back to AnnJi](https://aibio.space/news/avenue-therapeutics-ends-aj201-license-transfers-program-back-annji/) |
| 2025-04-30 | TriSalus Life Sciences [TLSI](https://aibio.space/companies/trisalus-life-sciences/) | Other deal | [TriSalus agrees to sell 5,500,000 shares at $4.00 in $22.0 million private placement](https://aibio.space/news/trisalus-agrees-sell-5-500-000-shares-4-00-22-0-million-private/) |
| 2025-04-21 | Jazz Pharmaceuticals [JAZZ](https://aibio.space/companies/jazz-pharmaceuticals/) | Takeover | [Jazz Pharmaceuticals completes acquisition of Chimerix for about $935 million in cash](https://aibio.space/news/jazz-pharmaceuticals-completes-acquisition-chimerix-about-935-million/) |
| 2025-04-21 | Scilex Holding [SCLX](https://aibio.space/companies/scilex/) | Deal ended | [Scilex unit Semnur amends Denali merger deal, moves outside date to September 30, 2025](https://aibio.space/news/scilex-unit-semnur-amends-denali-merger-deal-moves-outside-date/) |
| 2025-04-15 | Tvardi Therapeutics [TVRD](https://aibio.space/companies/tvardi-therapeutics/) | Other deal | [Cara Therapeutics (now Tvardi Therapeutics) closes merger with Tvardi, 1-for-3 reverse split](https://aibio.space/news/cara-therapeutics-now-tvardi-therapeutics-closes-merger-tvardi-1-3/) |
| 2025-04-15 | OS Therapies [OSTX](https://aibio.space/companies/os-therapies/) | Other deal | [OS Therapies completes purchase of Advaxis immunotherapy assets from Ayala](https://aibio.space/news/os-therapies-completes-purchase-advaxis-immunotherapy-assets-ayala/) |
| 2025-04-14 | Coherus Oncology [CHRS](https://aibio.space/companies/coherus-oncology/) | Other deal | [Coherus BioSciences (now Coherus Oncology) completes UDENYCA sale, gets $483.4 million upfront](https://aibio.space/news/coherus-biosciences-now-coherus-oncology-completes-udenyca-sale-gets/) |
| 2025-04-14 | Coherus Oncology [CHRS](https://aibio.space/companies/coherus-oncology/) | Other deal | [Coherus (now Coherus Oncology) completes UDENYCA sale to Intas for $483.4 million upfront](https://aibio.space/news/coherus-now-coherus-oncology-completes-udenyca-sale-intas-483-4/) |
| 2025-04-10 | Pulmatrix [PULM](https://aibio.space/companies/pulmatrix/) | Other deal | [Pulmatrix and Cullgen amend merger agreement, switching to a one-step merger](https://aibio.space/news/pulmatrix-cullgen-amend-merger-agreement-switching-one-step-merger/) |
| 2025-04-10 | Pulmatrix [PULM](https://aibio.space/companies/pulmatrix/) | Deal ended | [Pulmatrix amends Cullgen merger agreement to a one-step merger](https://aibio.space/news/pulmatrix-amends-cullgen-merger-agreement-one-step-merger/) |
| 2025-04-07 | Zevra Therapeutics [ZVRA](https://aibio.space/companies/zevra-therapeutics/) | Asset sale or purchase | [Zevra Therapeutics closes $150 million sale of rare pediatric disease priority review voucher](https://aibio.space/news/zevra-therapeutics-closes-150-million-sale-rare-pediatric-disease/) |
| 2025-04-01 | Lantheus Holdings [LNTH](https://aibio.space/companies/lantheus/) | Other deal | [Lantheus completes Evergreen Theragnostics acquisition, paying about $275 million in cash](https://aibio.space/news/lantheus-completes-evergreen-theragnostics-acquisition-paying-about/) |
| 2025-04-01 | Tvardi Therapeutics [TVRD](https://aibio.space/companies/tvardi-therapeutics/) | Other deal | [Cara Therapeutics (now Tvardi Therapeutics) stockholders approve Tvardi merger share issuance](https://aibio.space/news/cara-therapeutics-now-tvardi-therapeutics-stockholders-approve-tvardi/) |
| 2025-03-31 | ProKidney [PROK](https://aibio.space/companies/prokidney/) | Other deal | [ProKidney files to move incorporation from the Cayman Islands to Delaware](https://aibio.space/news/prokidney-files-move-incorporation-cayman-islands-delaware/) |
| 2025-03-28 | Kyntra Bio [KYNB](https://aibio.space/companies/kyntra-bio/) | Deal ended | [FibroGen (now Kyntra Bio) extends Fortis merger option deadline to December 31, 2027](https://aibio.space/news/fibrogen-now-kyntra-bio-extends-fortis-merger-option-deadline-december/) |
| 2025-03-26 | Whitehawk Therapeutics [WHWK](https://aibio.space/companies/whitehawk-therapeutics/) | Asset sale or purchase | [Whitehawk Therapeutics (formerly Aadi Bioscience) completes $102.4 million sale of Aadi Subsidiary](https://aibio.space/news/whitehawk-therapeutics-formerly-aadi-bioscience-completes-102-4/) |
| 2025-03-26 | Whitehawk Therapeutics [WHWK](https://aibio.space/companies/whitehawk-therapeutics/) | Asset sale or purchase | [Whitehawk Therapeutics completes sale of Aadi Subsidiary to Kaken for $102.4 million](https://aibio.space/news/whitehawk-therapeutics-completes-sale-aadi-subsidiary-kaken-102-4/) |
| 2025-03-25 | GridAI Technologies [GRDX](https://aibio.space/companies/gridai-technologies/) | Other deal | [Entero (now GridAI Technologies) signs deal to unwind ImmunogenX merger](https://aibio.space/news/entero-now-gridai-technologies-signs-deal-unwind-immunogenx-merger/) |
| 2025-03-19 | Bausch Health Companies [BHC](https://aibio.space/companies/bausch-health-companies/) | Other deal | [Bausch Health launches $4.0 billion senior secured notes offering to refinance debt](https://aibio.space/news/bausch-health-launches-4-0-billion-senior-secured-notes-offering/) |
| 2025-03-18 | Kalaris Therapeutics [KLRS](https://aibio.space/companies/kalaris-therapeutics/) | Other deal | [AlloVir (now Kalaris Therapeutics) completes Kalaris merger; shares to trade as KLRS on March 19](https://aibio.space/news/allovir-now-kalaris-therapeutics-completes-kalaris-merger-shares-trade/) |
| 2025-03-18 | Kalaris Therapeutics [KLRS](https://aibio.space/companies/kalaris-therapeutics/) | Other deal | [Kalaris Therapeutics closes merger with AlloVir; stock trades as KLRS from March 19, 2025](https://aibio.space/news/kalaris-therapeutics-closes-merger-allovir-stock-trades-klrs-march-19/) |
| 2025-03-13 | Pliant Therapeutics [PLRX](https://aibio.space/companies/pliant-therapeutics/) | Other deal | [Pliant Therapeutics, Inc. adopts stockholder rights plan with $12.64 exercise price](https://aibio.space/news/pliant-therapeutics-inc-adopts-stockholder-rights-plan-12-64-exercise/) |
| 2025-03-13 | Pliant Therapeutics [PLRX](https://aibio.space/companies/pliant-therapeutics/) | Other deal | [Pliant Therapeutics adopts one-year shareholder rights plan after stock buildup](https://aibio.space/news/pliant-therapeutics-adopts-one-year-shareholder-rights-plan-after/) |
| 2025-03-12 | Kalaris Therapeutics [KLRS](https://aibio.space/companies/kalaris-therapeutics/) | Other deal | [AlloVir (now Kalaris Therapeutics) stockholders approve Kalaris merger and change of control](https://aibio.space/news/allovir-now-kalaris-therapeutics-stockholders-approve-kalaris-merger/) |
| 2025-03-12 | Kalaris Therapeutics [KLRS](https://aibio.space/companies/kalaris-therapeutics/) | Other deal | [AlloVir (now Kalaris Therapeutics) stockholders approve merger with Kalaris](https://aibio.space/news/allovir-now-kalaris-therapeutics-stockholders-approve-merger-kalaris/) |
| 2025-03-11 | Anika Therapeutics [ANIK](https://aibio.space/companies/anika-therapeutics/) | Asset sale or purchase | [Anika Therapeutics sells Parcus Medical to Medacta for $4,500,000 in cash](https://aibio.space/news/anika-therapeutics-sells-parcus-medical-medacta-4-500-000-cash/) |
| 2025-03-11 | Anika Therapeutics [ANIK](https://aibio.space/companies/anika-therapeutics/) | Asset sale or purchase | [Anika Therapeutics completes sale of Parcus Medical to Medacta Group](https://aibio.space/news/anika-therapeutics-completes-sale-parcus-medical-medacta-group/) |
| 2025-03-10 | Fortress Biotech [FBIO](https://aibio.space/companies/fortress-biotech/) | Other deal | [Fortress Biotech's Checkpoint unit agrees to Sun Pharma deal at $4.10 a share plus CVR](https://aibio.space/news/fortress-biotechs-checkpoint-unit-agrees-sun-pharma-deal-4-10-share/) |
| 2025-03-05 | Jazz Pharmaceuticals [JAZZ](https://aibio.space/companies/jazz-pharmaceuticals/) | Takeover | [Jazz Pharmaceuticals agrees to acquire Chimerix for $8.55 per share in cash](https://aibio.space/news/jazz-pharmaceuticals-agrees-acquire-chimerix-8-55-share-cash/) |
| 2025-03-03 | Jade Biosciences [JBIO](https://aibio.space/companies/jade-biosciences/) | Other deal | [Aerovate Therapeutics (now Jade Biosciences) files merger material from Jade](https://aibio.space/news/aerovate-therapeutics-now-jade-biosciences-files-merger-material-jade/) |
| 2025-02-27 | Mustang Bio [MBIO](https://aibio.space/companies/mustang-bio/) | Other deal | [Mustang Bio sells Worcester equipment to AbbVie for $1.0 million and exits facility lease](https://aibio.space/news/mustang-bio-sells-worcester-equipment-abbvie-1-0-million-exits/) |
| 2025-02-27 | Crescent Biopharma [CBIO](https://aibio.space/companies/crescent-biopharma/) | Reverse merger | [Crescent still expects GlycoMimetics reverse merger to close in second quarter of 2025](https://aibio.space/news/crescent-still-expects-glycomimetics-reverse-merger-close-second/) |
| 2025-02-27 | Mustang Bio [MBIO](https://aibio.space/companies/mustang-bio/) | Other deal | [Mustang Bio sells fixed assets to AbbVie for $1.0 million and exits Worcester facility](https://aibio.space/news/mustang-bio-sells-fixed-assets-abbvie-1-0-million-exits-worcester/) |
| 2025-02-18 | PRF Technologies [PRFX](https://aibio.space/companies/prf-technologies/) | Takeover | [PainReform (now PRF Technologies) agrees to buy DeepSolar business for shares and warrants](https://aibio.space/news/painreform-now-prf-technologies-agrees-buy-deepsolar-business-shares/) |
| 2025-02-06 | Alumis [ALMS](https://aibio.space/companies/alumis/) | Other deal | [Alumis agrees to all-stock merger with ACELYRIN, with pro forma cash of about $737 million](https://aibio.space/news/alumis-agrees-all-stock-merger-acelyrin-pro-forma-cash-about-737/) |
| 2025-02-06 | Alumis [ALMS](https://aibio.space/companies/alumis/) | Other deal | [Alumis and ACELYRIN agree to all-stock merger with $737 million pro forma cash](https://aibio.space/news/alumis-acelyrin-agree-all-stock-merger-737-million-pro-forma-cash/) |
| 2025-02-03 | Baxter International [BAX](https://aibio.space/companies/baxter-international/) | Asset sale or purchase | [Baxter completes Kidney Care business sale and receives about $3.71 billion in net cash proceeds](https://aibio.space/news/baxter-completes-kidney-care-business-sale-receives-about-3-71-billion/) |
| 2025-01-21 | Whitehawk Therapeutics [WHWK](https://aibio.space/companies/whitehawk-therapeutics/) | Asset sale or purchase | [Aadi Bioscience (now Whitehawk Therapeutics) seeks vote on $100 million FYARRO sale](https://aibio.space/news/aadi-bioscience-now-whitehawk-therapeutics-seeks-vote-100-million/) |
| 2025-01-14 | Coherus Oncology [CHRS](https://aibio.space/companies/coherus-oncology/) | Deal ended | [Coherus BioSciences (now Coherus Oncology) seeks vote on $483.4 million UDENYCA sale](https://aibio.space/news/coherus-biosciences-now-coherus-oncology-seeks-vote-483-4-million/) |
| 2025-01-07 | Lunai Bioworks [LNAI](https://aibio.space/companies/lunai-bioworks/) | Other deal | [Renovaro (now Lunai Bioworks) signs binding letter to buy Predictive Oncology](https://aibio.space/news/renovaro-now-lunai-bioworks-signs-binding-letter-buy-predictive/) |
| 2025-01-06 | Bio Green Med Solution [BGMS](https://aibio.space/companies/bio-green-med-solution/) | Other deal | [Cyclacel (now Bio Green Med Solution) agrees to sell $3.1 million of preferred stock](https://aibio.space/news/cyclacel-now-bio-green-med-solution-agrees-sell-3-1-million-preferred/) |
| 2025-01-03 | Eton Pharmaceuticals [ETON](https://aibio.space/companies/eton-pharmaceuticals/) | Other deal | [Eton Pharmaceuticals completes acquisition of Galzin from Teva for $7.0 million at closing](https://aibio.space/news/eton-pharmaceuticals-completes-acquisition-galzin-teva-7-0-million/) |
| 2024-12-26 | Aspire-Lakewood Holdings [ASBP](https://aibio.space/companies/aspire-lakewood/) | Other deal | [PowerUp Acquisition (now Aspire-Lakewood) gets loan of up to $500,000 before merger](https://aibio.space/news/powerup-acquisition-now-aspire-lakewood-gets-loan-up-500-000-before/) |
| 2024-12-26 | Serina Therapeutics [SER](https://aibio.space/companies/serina-therapeutics/) | Asset sale or purchase | [Serina Therapeutics sells UniverXome to Juvenescence, which takes on $11.2 million of debt](https://aibio.space/news/serina-therapeutics-sells-univerxome-juvenescence-which-takes-11-2/) |
| 2024-12-18 | Tvardi Therapeutics [TVRD](https://aibio.space/companies/tvardi-therapeutics/) | Deal ended | [Cara Therapeutics (now Tvardi Therapeutics) agrees all-stock merger with private Tvardi](https://aibio.space/news/cara-therapeutics-now-tvardi-therapeutics-agrees-all-stock-merger/) |
| 2024-12-16 | Neuphoria Therapeutics [NEUP](https://aibio.space/companies/neuphoria-therapeutics/) | Other deal | [Bionomics (now Neuphoria Therapeutics) wins court approval for its US move](https://aibio.space/news/bionomics-now-neuphoria-therapeutics-wins-court-approval-us-move/) |
| 2024-12-02 | Nektar Therapeutics [NKTR](https://aibio.space/companies/nektar-therapeutics/) | Asset sale or purchase | [Nektar completes sale of Huntsville, Alabama plant to Ampersand affiliate](https://aibio.space/news/nektar-completes-sale-huntsville-alabama-plant-ampersand-affiliate/) |
| 2024-11-25 | TuHURA Biosciences [HURA](https://aibio.space/companies/tuhura-biosciences/) | Takeover | [TuHURA Biosciences signs letter of intent to acquire Kineta's KVA12123](https://aibio.space/news/tuhura-biosciences-signs-letter-intent-acquire-kinetas-kva12123/) |
| 2024-11-08 | Akari Therapeutics Plc [AKTX](https://aibio.space/companies/akari-therapeutics/) | Other deal | [Akari Therapeutics shareholders approve share issuance for Peak Bio merger](https://aibio.space/news/akari-therapeutics-shareholders-approve-share-issuance-peak-bio-merger/) |
| 2024-11-07 | Geron [GERN](https://aibio.space/companies/geron/) | Other deal | [Geron completes $250 million Royalty Pharma and Pharmakon financings](https://aibio.space/news/geron-completes-250-million-royalty-pharma-pharmakon-financings/) |
| 2024-11-07 | Palvella Therapeutics [PVLA](https://aibio.space/companies/palvella-therapeutics/) | Other deal | [Pieris (now Palvella Therapeutics) files merger partner's Phase 3 dosing news](https://aibio.space/news/pieris-now-palvella-therapeutics-files-merger-partners-phase-3-dosing/) |
| 2024-11-05 | MindMaze Therapeutics Holding SA [MMTX](https://aibio.space/companies/mindmaze-therapeutics/) | Reverse merger | [Relief Therapeutics (now MindMaze) signs non-binding LOI for Renexxion reverse merger](https://aibio.space/news/relief-therapeutics-now-mindmaze-signs-non-binding-loi-renexxion/) |
| 2024-10-31 | Lyell Immunopharma [LYEL](https://aibio.space/companies/lyell-immunopharma/) | Other deal | [Lyell Immunopharma completes acquisition of ImmPACT Bio](https://aibio.space/news/lyell-immunopharma-completes-acquisition-immpact-bio/) |
| 2024-10-29 | Immunome [IMNM](https://aibio.space/companies/immunome/) | Asset sale or purchase | [Immunome buys licensed Zentalis ROR1 assets for 1,805,502 shares](https://aibio.space/news/immunome-buys-licensed-zentalis-ror1-assets-1-805-502-shares/) |
| 2024-10-28 | OSR Health [OSRH](https://aibio.space/companies/osr-health/) | Deal ended | [Bellevue Life Sciences Acquisition (now OSR Health) lends $300,000 to OSR Holdings](https://aibio.space/news/bellevue-life-sciences-acquisition-now-osr-health-lends-300-000-osr/) |

## How this tracker works

We add a deal when a merger agreement, tender offer, S-4, proxy or closing is filed with the SEC or announced by the company. Ownership splits are the ones the filing states. Every row links our story, and every story links the filing, court record or release it is based on. Something missing or wrong? [Tell the editors](https://aibio.space/reputation/#correction).

News, not investment advice. [How we work](https://aibio.space/disclosures/).

---
Source page: https://aibio.space/reverse-merger-tracker/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Biotech reverse merger and M&A tracker", 2026-10-31, https://aibio.space/reverse-merger-tracker/